Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by LivaNova PLC
< Previous
1
2
Next >
LivaNova to Present at the Baird Global Healthcare Conference
August 19, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Second-Quarter 2024 Results
July 31, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Second-Quarter 2024 Results
June 18, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
June 06, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Goldman Sachs Healthcare Conference
May 23, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2024 Results
May 01, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
April 30, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
April 25, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2024 Results
March 21, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
March 20, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
March 05, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
March 04, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
February 21, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
February 05, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Wind Down Advanced Circulatory Support Business Unit
January 08, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results
January 04, 2024
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Piper Sandler Healthcare Conference
November 09, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Third-Quarter 2023 Results
November 01, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Stifel and Wolfe Healthcare Conferences
October 25, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Board Appoints J. Christopher Barry as New Director
October 06, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
September 21, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Third-Quarter 2023 Results
September 20, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark
August 30, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Present at the Baird Global Healthcare Conference
August 24, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports Second-Quarter 2023 Results
July 26, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce Second-Quarter 2023 Results
June 14, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
June 13, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Reports First-Quarter 2023 Results
May 03, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova Board of Directors Announce Leadership Changes
April 14, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
LivaNova to Announce First-Quarter 2023 Results
March 22, 2023
From
LivaNova PLC
Via
Business Wire
Tickers
LIVN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.